Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III … – Trading Markets (press release)

posted on Dec 22 by in the Uncategorized category

Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III ...
Trading Markets (press release)
[2] * Tekturna/Rasilez(aliskiren) ? a first-in-class direct renin inhibitor approved for treatment of hypertension that is also currently in Phase III ...

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes